The Synchronous Prevalence of Colorectal Neoplasms in Patients with Stomach Cancer
´ëÇÑ´ëÀåÇ×¹®ÇÐȸÁö 2011³â 27±Ç 5È£ p.246 ~ p.251
ÀÌ»ó¼ö(Lee Sang-Su) - Gyeongsang National University School of Medicine Department of Internal Medicine
Á¤¿îÅÂ(Jung Woon-Tae) - °æ»ó´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç
±èÂ÷¿µ(Kim Cha-Young) - Gyeongsang National University School of Medicine Department of Internal Medicine
ÇÏâÀ±(Ha Chang-Yoon) - °æ»ó´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç
¹ÎÇöÁÖ(Min Hyun-Ju) - °æ»ó´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç
±èÇöÁø(Kim Hyun-Jin) - °æ»ó´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç
±èÅÂÈ¿(Kim Tae-Hyo) - °æ»ó´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç
Abstract
Purpose: The association between stomach cancer and colorectal cancer is controversial. The purpose of this study was to determine the synchronous prevalence of colorectal neoplasms in patients with stomach cancer.
Methods: A total of 123 patients with stomach cancer (86 male) and 246 consecutive, age- and sex-matched persons without stomach cancer were analyzed from July 2005 to June 2010. All of them underwent colonoscopy within 6 months after undergoing gastroscopy.
Results: The prevalence of colorectal neoplasms was significantly higher in the stomach cancer group (35.8%) than in the control group (17.9%) (P < 0.001). Colorectal neoplasms were more prevalent in the patients with stomach cancer (odds ratio [OR], 3.10; 95% confidence interval [CI], 1.71 to 5.63). In particular, the difference in the prevalence of colorectal neoplasms was more prominent in the patients above 50 years old (OR, 3.54; 95% CI, 1.80 to 6.98).
Conclusion: The results showed that the synchronous prevalence of colorectal neoplasms was higher in patients with stomach cancer than in those without stomach cancer. Therefore, patients with stomach cancer should be regarded as a high-risk group for colorectal neoplasms, and colonoscopy should be recommended for screening.
Å°¿öµå
Colorectal neoplasms, Stomach neoplasms, Colonoscopy, Gastroscopy
KMID :
0356720110270050246
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
À¯È¿¼º°á°ú(Recomendation)
The prevalence of colorectal neoplasms was significantly higher in the stomach cancer group (35.8%) than in the control group (17.9%, P < 0.001).